MedPath

The Effect of Blood Donation on Hematological and Iron Indices and Detection of Autologous Blood Transfusion

Not Applicable
Active, not recruiting
Conditions
Healthy
Interventions
Procedure: Blood donation and blood transfusion
Registration Number
NCT04514978
Lead Sponsor
University of Copenhagen
Brief Summary

Blood donations is a essential and crucial in the clinic. Normal biological variation of relevant biomarkers and hormones before the donation of 450 mL whole blood as well as the expected alterations in systemic levels of plasma iron indices and RBC measures up to 4 weeks after donation in healthy, non-anemic, young men and women is investigated

Likewise, the possibilities for detecting autologous blood transfusion is investigated.

Detailed Description

Blood donations is a essential and crucial in the clinic. A whole blood donation results in the loss of 450-525 mL whole blood in eight to ten minutes and is known to reduce body iron stores with 200-265 mg iron depending on the donor's age, hematocrit and sex and accounts for 25% of average tissue iron stores in men and up to 75% in women.In the present study, the investigators aimed at thoroughly evaluate normal biological variation of relevant biomarkers and hormones before the donation of 450 mL whole blood as well as the expected alterations in systemic levels of plasma iron indices and red blood cell measures up to 4 weeks after donation in healthy, non-anemic, young men and women

Likewise, doping in sport is a major problem concerning both the health of the athletes and the integrity of sports. Despite major improvements in anti-doping work in recent years, it is still impossible to test for all existing and future doping strategies, such as manipulation with blood oxygen carrying capacity. A well-known doping strategy is autologous blood transfusion (ABT), and at present, the detection of ABT is a challenge for anti-doping authorities. The hypotheses for this study are that 1) ret% and abnormal blood profile score (ABPS) have higher sensitivity to micro-dose ABT compared to current variables in the Athlete Biological Passport (ABP); 2) The plasma concentration of hepcidin and erythroferrone (ERFE) is sensitive to micro-dose ABT; 3) Gender-specific variations in hematologic variables affect the interpretation of the athlete's biological passport.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
48
Inclusion Criteria
  • Relative maximum oxygen uptake (VO2-max) of at least 55 ml O2/min/kg for male participants and 50 ml O2/min/kg for female participants
Exclusion Criteria
  • Age
  • Insufficient fitness level
  • Blood donation 3 months prior to enrollment
  • Altitude exposure 2 months before enrollment
  • Hypertension

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Blood donation and transfusionBlood donation and blood transfusionDonation and reinfusion of 1 unit whole blood and 130 mL packed red blood cells, respectively. Blood samples were collected at 8 weeks prior to donation for 12 subjects and 2 weeks prior to donation by 12 subjects. Blood samples were collected 3, 7, 14, 21, and 28 days after donation and 3, 6, 24 hours and 2, 3 and 6 days after reinfusion of blood.
Primary Outcome Measures
NameTimeMethod
Hemoglobin centration6 days after reinfusion

The effect of the intervention on \[Hb\] levels will be investigated

reticulocyte percentage6 days after reinfusion

The effect of the intervention on ret% levels will be investigated

Homeostatic markers of iron metabolism6 days after reinfusion

Markers of iron metabolism such as hepcidin and erythroferrone are collected and analyzed for evaluation of iron metabolism during and after donation and reinfusion of blood.

OFF-score6 days after reinfusion

The effect of the intervention on OFF-score (an algorithm computed from reticulocyte percentage and hemoglobin concentration resulting in a arbitrary value) will be investigated

Secondary Outcome Measures
NameTimeMethod
Endurance exercise performance measured as a preloaded 400 kcal time-trial6 days after reinfusion.

Endurance exercise performance are measured in a subgroup of 13 subjects.

Mean corpuscular concentration6 days after reinfusion.

Markers of red blood cell size and hemoglobin content are collected and analyzed for Determining the impact of donation and reinfusion of blood.

Dried Blood Spots6 days after reinfusion.

Dried blood spots will be analyzed for the CD71/Band3 concentration as well as transcriptomic markers for reticolucytes including the ALAS2 L and LC.

Maximal oxugen uptake (VO2max)6 days after reinfusion.

Maximal aerobic capacity is measured via a maximal oxygen uptake incremental test in a subgroup of 13 subjects.

Mean corpuscular hemoglobin concentration6 days after reinfusion.

Markers of red blood cell size and hemoglobin content are collected and analyzed for Determining the impact of donation and reinfusion of blood.

Mean corpuscular volume6 days after reinfusion.

Markers of red blood cell size and hemoglobin content are collected and analyzed for Determining the impact of donation and reinfusion of blood.

Trial Locations

Locations (1)

Department of Nutrition, Exercise and Sports

🇩🇰

Copenhagen, Denmark

© Copyright 2025. All Rights Reserved by MedPath